TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer

OBJECTIVE: To assess the feasibility and preliminary efficacy of adding cetuximab to standard chemoradiotherapy for muscle‐invasive bladder cancer. PATIENTS AND METHODS: TUXEDO was a prospective, single‐arm, open‐label, phase I/II trial conducted in six UK hospitals. Cetuximab was administered with...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Nicholas D., Liu, Wenyu, Pirrie, Sarah, Kaur, Baljit, Hendron, Carey, Ford, Daniel, Zarkar, Anjali, Viney, Richard, Southgate, Elizabeth, Desai, Amisha, Hussain, Syed A., Barber, Jim, Syndikus, Isabel, Malik, Zafar, Eswar, Chinnamani, Mangar, Stephen, Money‐Kyrle, Julian, Lydon, Anna, Van Der Voet, Johannes, James, Nicholas, Ford, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087008/
https://www.ncbi.nlm.nih.gov/pubmed/35908256
http://dx.doi.org/10.1111/bju.15864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087008/
https://www.ncbi.nlm.nih.gov/pubmed/35908256
http://dx.doi.org/10.1111/bju.15864

Ejemplares similares